Veradigm | MDRX - Pre Tax Profit


Veradigm reported $35.3M in Pre-Tax Profit for its fiscal quarter ending in September of 2022.





Pre Tax Profit Change Date
Ambu A/S DKK 153M 3M Dec/2025
Amplifon EUR 7.16M 44.39M Sep/2025
Cardinal Health USD 598M 214M Sep/2025
Centene USD -6.67B 6.42B Sep/2025
Charles River Laboratories USD 170.03M 98.62M Sep/2025
Cigna USD 2.3B 274M Sep/2025
Coloplast 1.79B 236M Dec/2025
Convatec Group USD 52M 6.3M Jun/2024
CVS Health USD 1.35B 4.84B Dec/2025
Diasorin EUR 50.55M 11.9M Sep/2025
Elevance Health USD 215M 1.19B Dec/2025
General Electric Aerospace USD 2.2B 654M Mar/2026
Humana USD 527M 214M Sep/2025
IQVIA Holdings USD 537M 5.62B Dec/2025
Laboratory Of America USD 337M 32.3M Sep/2025
Maximus USD 126.27M 25.8M Dec/2025
McKesson USD 1.4B 344M Sep/2025
Med Life RON 11.88M 28.54M Sep/2025
Molina Healthcare USD -214M 448M Dec/2025
Omnicell USD 9.7M 750K Sep/2025
Oriola-kd EUR 2.2M 7.8M Sep/2025
Owens Minor USD 35.71M 5.37M Sep/2025
Quest Diagnostics USD 330M 6M Dec/2025
Rede D'or Sao Luiz BRL 1.49B 405.65M Dec/2025
Siemens Healthineers EUR 736M 6M Jun/2025
Sonova Holding CHF 234.3M 159.4M Dec/2025
Supermax Corporation Bhd MYR -143.04M 41.22M Sep/2025
UnitedHealth USD -720M 3.95B Dec/2025
Veeva Systems USD 436.85M 14.82M Sep/2025
Veradigm USD 35.3M 13.95M Sep/2022
Xerox USD 365M 347M Sep/2025